MedTrace Logo

EAA/Therapy for Treating Children With ADHD

NCT02482649 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2015-06-26

No results posted yet for this study

Summary

The aim of this study is 1) to investigate clinical effects of equine-assisted activities and therapy (EAA/T) for treating attention-deficit/hyperactivity disorder (ADHD) and 2) to compare the clinical effect of EAA/T and drug therapy in children 6-13-years-of-age. This study is designed as a 12-week, prospective, open labeled trial, including 24 sessions of EAA/T. Forty six subjects will be enrolled and various clinical tests will be administered at baseline and after EAA/T or drug therapy.

Conditions

  • Attention Deficit Hyperactivity Disorder

Interventions

BEHAVIORAL

EAA/T

bi-weekly for 12weeks

DRUG

Methylphenidate

dosage adjustment according to clinical effectiveness, QD for 12weeks

DRUG

Atomoxetine

dosage adjustment according to clinical effectiveness, QD or BID, for 12weeks

Sponsors & Collaborators

  • Samsung Electronics

    collaborator INDUSTRY

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Yoo-Sook Joung, M.D.,Ph.D. · Department of Psychiatry, Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-08-31
Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02482649 on ClinicalTrials.gov